Cannabis-focused biopharmaceutical company Avicanna Inc. AVCN AVCNF 0NN confirmed Tuesday that it had closed a non-brokered private placement raising CA$3.9 million ($3.16 million). Under the offering, the company
issued an aggregate of 4.59 million units, at a price of CA$0.85 per unit.
Each unit consisted of one common share of the company and one share purchase warrant. Each warrant is exercisable into one Avicanna’s share at a price of CA$1.10 per warrant share in the following three years from the closing of the offering.
The Toronto-based company plans to use the collected proceeds to support standard working capital activities, general and administrative expenses, expenditures related to production and manufacturing, as well as research and clinical development.
In connection with the closing of the offering, the company paid aggregate finders' fees of approximately $65,000 to eligible finders.
In addition, the company announced the proposed repricing of 1.59 million common share purchase warrants, expiring September 20, 2024, issued to the lender that advanced the secured term loan in the principal amount of $2.12 million to the company in August 2021. The exercise price of the term loan warrants will be repriced from $1.13 to $1.10 being the same exercise price of the warrants issued in connection with the offering.
More recent news from Avicanna:
Avicanna Ships Its Feminized Cannabis Seeds To Peru And Argentina
Avicanna Files Patent For New Cannabinoid-Based Epilepsy Medication
Avicanna Completes Registration And Commercial Export Of Pura Earth CBD Brand In Ecuador
Avicanna Reaches Brazil With Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts
Price Action
Avicanna’s shares closed Tuesday market session 3.17% higher at 64 cents per share.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!